Even I Was Surprised to See CBD in These States

You are receiving this as part of your free subscription to Cannabis Profits Daily. To remove your email from this list, unsubscribe here.

Monday, April 1, 2019 CBD in These States Means Incredible Gains for You By Greg Miller Proof that 2019 is the "Year of CBD" continues to pour in. And that means big profits for those health and wellness companies with leading brands and an eye towards becoming global consumer packaged goods giants. Late last week, Walgreens announced it would begin selling CBD products in its stores. "This product offering is in line with our efforts to provide a wider range of accessible health and wellbeing products and services to best meet the needs and preferences of our customers," Walgreens spokesman Brian Faith said in a statement. More to the point, this product offering is in line with the announcement Walgreens rival CVS made days before, which we reported on here. In a true show of that rivalry, Walgreens is attempting to outpace CVS. While the initial CVS rollout covered 800 stores across eight states, Walgreens will begin carrying the products in nearly 1,500 stores across nine states. None of this is particularly surprising. As soon as the Farm Bill passed, effectively legalizing CBD nationwide, we knew it was only a matter of time before major retailers stepped into the game. And competition between chains is not only expected, but also healthy for the growth of the cannabis industry. But that's not to say there's nothing surprising in these deals. The sale of CBD through major retailers in these states is unexpected, and it signals something huge for the cannabis markets as a whole... CBD at CVS Is a Big Win for This Cannabis Stock Discover Our Top Cannabis Picks for 2019 Here's Why I Want the "Starbucks of Cannabis" This Could Put You on the Fast-Track to More Wealth Than You've Ever Thought Possible Here at the National Institute for Cannabis Investors, we have one goal: to be your official source for cannabis investing. We've assembled the most successful cannabis CEOs and investors in modern history. As well as the most politically connected players in this industry. For the first time ever, we've all joined forces. We're not going to waste a moment. So make sure you don't miss your chance to be a part of history. Just click here to learn more. Never in my career have I heard of a single industry having so many IPOs in such a short period. Right now, there's a real chance to get into a once-in-a-lifetime IPO one... two... even three times a MONTH for the next year. That's why we created a one-of-a-kind venture here at the NICI... To guide people to making a fortune is this red-hot industry. Heck, we have an entire division staffed with experts with the sole purpose of creating new millionaires. And today, we have a simple goal. To show at least 2,000 average investors living in the United States how to become millionaires from this misunderstood industry. Just click the link below to find out how you can become one of them. You are receiving this e-mail at its028@gmail.com, as a part of your subscription. Remove your email from this list: Unsubscribe © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. Privacy Policy | Terms & Conditions